phenyl acetate has been researched along with Protein Aggregation, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucciantini, M; Cesaro, S; Leri, M; Palazzi, L; Polverino de Laureto, P; Stefani, M | 1 |
| Dadashpour, S; Emami, S; Irannejad, H; Ozadali, K; Tuylu Kucukkilinc, T; Unsal Tan, O | 1 |
2 other study(ies) available for phenyl acetate and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol.
Topics: Acetates; alpha-Synuclein; Antioxidants; Antiparkinson Agents; Cell Line, Tumor; Cell Survival; Cyclopentane Monoterpenes; Humans; Levodopa; Molecular Structure; Parkinson Disease; Phenylethyl Alcohol; Protein Aggregation, Pathological; Protein Binding; Protein Conformation; Proteolysis; Pyrans | 2020 |
Design, synthesis and in vitro study of 5,6-diaryl-1,2,4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitors.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Cyclooxygenase 2 Inhibitors; Drug Design; Molecular Docking Simulation; Molecular Structure; Permeability; Plaque, Amyloid; Protein Aggregation, Pathological; Protein Stability; Structure-Activity Relationship; Triazines | 2015 |